Saturday
03.28.2026
10:22 AM
Welcome
Guest
Main
|
Registration
|
Login
|
RSS
Home page
Login form
Search
Calendar
«
December 2022
»
Su
Mo
Tu
We
Th
Fr
Sa
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Entries archive
2018 June
2018 July
2021 March
2022 January
2022 February
2022 March
2022 May
2022 August
2022 December
2023 January
2024 October
2025 April
My site
Blog
Main
»
2022
»
December
08 December, Thursday
9:48 AM
Phase III trial demonstrated Jardiance is the first SGLT2 inhibitor to show statistically significant reduction in blood sugar levels in chi
(0)